COVID-19 DETECTION TECHNOLOGIES Diagnostic Kit for Novel Coronavirus (COVID-19) IgM & IgG ANTIBODY (Colloidal Gold)
Coronavirus SARS-CoV-2 Detection Development by ND Pharma & Biotech
The emergence of new viral diseases, including the coronavirus SARS-CoV-2 (COVID 19) outbreak, highlighted the need for fast methods to detect and identify target viruses at scale.
The COVID-19 pandemic also illustrates how research efforts to develop drug treatments or vaccines are accelerated in times of urgent need. There is also a need for supplies and support for scientists working to curtail spread of the SARS-CoV-2 virus is urgent and immediate.
ND Pharma in association with certain partners support scientists working to understand the molecular mechanisms by which emerging viruses infect humans and animals, and to develop accurate detection methods.
We provide collaborative technical support, expertise and a variety of technologies to help all kind of operators, including public health institutions and governmental organizations in control and fight against this virus.
One of those technologies is our Diagnostic Kit for novel coronavirus (COVID-19) IgM & IgG ANTIBODY (Colloidal Gold Technology) with Top Precision, Specificity and Accuracy Levels (Independent Institution Testing Results)*
COVID-19 DETECTION TECHNOLOGIES Diagnostic Kit for Novel Coronavirus (COVID-19) IgM & IgG ANTIBODY (Colloidal Gold)
Coronavirus SARS-CoV-2 Detection and Assay Development by ND Pharma & Biotech
The novel coronavirus disease know as COVID-19 is characterized by fever, dry cough and fatigue leading to SARS-CoV-2 induced severe pneumonia. A number of patients have other symptoms as nasal obstruction, runny nose, sore throat, myalgia (muscular pain) and diarrhea. Severe progressing patients usually develop dyspnea and/or hypoxemia one week after onset. Severe affected patients can develop rapidly into acute respiratory distress syndrome, septic shock, metabolic acidosis, coagulopathies including clotting into arteries and veins, and multiple organ failure. In younger patients cytokines storm may lead into cerebral vascular accidents, ictus and brain death.
Every other day scientists, physicians and health professionals are discovering and knowing more and new situations derived from COVID-19 disease and such pandemic situation has causing hundreds of thousands of deaths, in special within elderly worldwide.
To know more regarding this disease, contact, immunity and effects within the human body, Test Kits are an essential tool for help to control evolution of infection and pandemic situation.
ACCURATE COST-EFFECTIVE
EASY TO OPERATE QUICK RESULTS IN 15 MINUTES UK REGISTERED ISO CERTIFIED CE MARKED
COVID-19 DETECTION TECHNOLOGIES Diagnostic Kit for Novel Coronavirus (COVID-19) IgM & IgG ANTIBODY (Colloidal Gold)
ND Pharma & Biotech Brand
Product Characteristics
20 Test Kits per Box
Instructions Manual English/Spanish/Portuguese
1 Bottle Reactive for Testing per Box
Performance Parameter
Individual Sealed Package Protection
Sensitivity and Specificity Clinically Tested Clinical Positive Samples
Clinical Negative Samples
*Testing and Performance Results Report Jointly developed with Affiliated Hospital N3, Sun Yat– Sen University and Guangzhou Infectious Diseases Hospital. Successfully obtained Project Approval on “ emergency Research for New coronavirus Pneumonia Infection” by Health Innovation Authorities in Guangzhou Province and Provincial High-Tech Industrial Development District Bureau
COVID-19 DETECTION TECHNOLOGIES Diagnostic Kit for Novel Coronavirus (COVID-19) IgM & IgG ANTIBODY (Colloidal Gold)
Interpretation of Results
Important Information Regarding Testing for COVID-19 Compared with single IgM or IgG detection systems, IgM-IgG combined detection has better specificity and sensitivity. It can be used for the rapid screening of COVID-19 carriers, both symptomatic or asymptomatic, in health and clinical environments as Hospitals, clinics, Elder Residences, Test Laboratories, Pharmacies and Physicians Offices (including but not limited to). Always refer positives to Health Authorities. Just in case of recent infection or symptoms ask for further tests and assistance from Health Professionals or direct yourself to local hospital and/or health centres.
Application Scenarios
HOSPITALS & CLINICS BUSINESS COMPANIES SCHOOL & UNIVERITY RESIDENCES & COMMUNITTIES HOMES
Product depicted within this information brochure and leaflet is Registered in the UK with the MHRA (Competent Authority of Medicines and Medical Devices of the United Kingdom). ND Pharma & Biotech Co. has received authorization to mark and brand product in accordance with Section 9 of IVD Guidance of the UK as Distributor of Product. © 2020 ND Pharma & Biotech Company Limited · UK · All Rights Reserved
MAKING LIFE BETTER
www.ndpharmabiotech.com
Coronavirus Disease 2019 Outbreak
COVID-19
ND Pharma & Biotech Co. 152-160 City Road, London, England United Kingdom
www.ndpharmabiotech.com info@ndpharmabiotech.com For further information and/or assistance contact us and/or your local distributor.
Copyright ©2018 ND Pharma & Biotech company Limited. The ND Pharma Logos, names and any other issues marked with „TM“ and/or © mars are property of ND Pharma & Biotech Company Limited and/or its affiliates. Depicted items here does not constitute an offer or invitation to treat neither implies any kind of guarantee over efficacy and or product applications, legality and/or effects. Please check your local authorities to confirm such extremes prior to any use and/or application.